adapalene vs desonide
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of adapalene and desonide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
No summary available.
Desonide cream is a low-strength steroid medicine. It helps reduce swelling, itching, and redness of the skin.
Information not available.
This cream treats skin problems that cause inflammation and itching. These problems are called corticosteroid-responsive dermatoses. Use it for no more than two weeks unless your doctor tells you to.
Information not available.
Desonide is a type of steroid. It works by reducing inflammation. This helps to relieve itching and other skin problems.
- • Dry skin
- • Contact dermatitis (skin rash)
- • Burning feeling on the skin where you put the medicine
- • Skin irritation
- • Itching
- • Pain
- • Rash
- • Pimple-like bumps
- • Swelling in your arms or legs
- Dry Skin 44,990
- Skin Burning Sensation 41,633
- Acne 39,264
- Erythema 38,379
- Skin Irritation 26,225
- Macular Degeneration 773
- Pain 376
- Nausea 364
- Headache 313
- Erythema 299
No specific warnings noted.
You should not use this medicine if you are allergic to any of its ingredients.
No pregnancy information available.
Tell your doctor if you are pregnant or breastfeeding before using this medicine. It is not known if desonide can harm an unborn baby or pass into breast milk.
Also Compare, Nearby Drugs
Compare adapalene with
Compare desonide with
How to Read This adapalene vs desonide Comparison
adapalene is classified in the Retinoid (Topical) drug class, while desonide sits within the Topical Corticosteroid class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adapalene has 190,491 submissions while desonide has 2,125. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adapalene or desonide.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.